- Investing Ideas
- /
- French Pharmaceuticals & Biotech High Growth Potential Companies
French Pharmaceuticals & Biotech High Growth Potential Companies
Results
13
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
ADOC | €5.92 | 0.3% | -44.6% | €93.4m | €6.30 | PS25.5x | E64.0% | n/a | ||
VLA | €2.24 | 6.8% | -43.8% | €344.5m | €6.83 | PS2.3x | E4.6% | n/a | ||
AELIS | €1.91 | -9.0% | -85.9% | €26.0m | €9.10 | PS2.4x | E33.8% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
MEDCL | €15.96 | -2.4% | 90.0% | €474.1m | €22.83 | PS35.3x | E115.4% | n/a | ||
GNFT | €3.49 | 5.6% | -4.8% | €173.5m | €9.45 | PE7.8x | E45.2% | n/a | ||
DIM | €203.90 | 0.9% | -8.5% | €19.5b | €224.71 | PE123.5x | E32.2% | 0.3% | ||
ERF | €48.22 | 4.6% | -13.4% | €9.0b | €58.08 | PE27.8x | E18.4% | 1.0% | ||
BOI | €26.00 | -3.7% | -37.8% | €439.3m | €33.30 | PE19.1x | E26.2% | 5.2% | ||
ALTHX | €0.56 | -6.4% | -46.2% | €3.9m | €6.20 | PS1.9x | E112.8% | n/a | ||
ALERS | €25.30 | 0% | 57.9% | €254.1m | €30.00 | PE38.3x | E29.0% | n/a | ||
IVA | €2.12 | -4.5% | -40.3% | €185.9m | €7.02 | PS9.6x | E31.6% | n/a |
Page 1 of 1